Teladoc Health (NYSE:TDOC) Sets New 52-Week Low After Analyst Downgrade

Shares of Teladoc Health, Inc. (NYSE:TDOC) hit a new 52-week low on Monday after Jefferies Financial Group lowered their price target on the stock from $10.00 to $8.00. Jefferies Financial Group currently has a hold rating on the stock. Teladoc Health traded as low as $6.38 and last traded at $6.45, with a volume of 2474952 shares trading hands. The stock had previously closed at $6.83.

Several other research analysts also recently commented on the stock. Royal Bank of Canada lifted their target price on shares of Teladoc Health from $11.00 to $12.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. Oppenheimer dropped their price target on Teladoc Health from $14.00 to $12.00 and set an “outperform” rating on the stock in a research report on Friday, January 24th. The Goldman Sachs Group lowered their price objective on shares of Teladoc Health from $16.00 to $13.00 and set a “buy” rating on the stock in a research note on Monday, March 3rd. Piper Sandler decreased their price target on shares of Teladoc Health from $13.00 to $12.00 and set an “overweight” rating on the stock in a research report on Thursday, February 27th. Finally, Bank of America reduced their target price on shares of Teladoc Health from $9.50 to $8.00 and set a “neutral” rating for the company in a research note on Friday, April 11th. Eleven research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $10.82.

Insider Buying and Selling

In other news, insider Adam C. Vandervoort sold 11,011 shares of Teladoc Health stock in a transaction dated Thursday, March 20th. The stock was sold at an average price of $8.42, for a total transaction of $92,712.62. Following the transaction, the insider now owns 64,308 shares in the company, valued at $541,473.36. The trade was a 14.62 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.95% of the stock is owned by insiders.

Institutional Investors Weigh In On Teladoc Health

Institutional investors have recently bought and sold shares of the company. Versant Capital Management Inc lifted its position in Teladoc Health by 313.8% during the 4th quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider’s stock worth $29,000 after buying an additional 2,441 shares in the last quarter. Whipplewood Advisors LLC bought a new position in shares of Teladoc Health in the 4th quarter valued at about $29,000. Lindbrook Capital LLC increased its stake in shares of Teladoc Health by 78.9% during the 4th quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider’s stock worth $33,000 after purchasing an additional 1,612 shares during the last quarter. Sterling Capital Management LLC grew its holdings in Teladoc Health by 776.7% during the fourth quarter. Sterling Capital Management LLC now owns 4,629 shares of the health services provider’s stock worth $42,000 after purchasing an additional 4,101 shares during the period. Finally, Pilgrim Partners Asia Pte Ltd bought a new stake in Teladoc Health in the fourth quarter valued at approximately $60,000. Institutional investors own 76.82% of the company’s stock.

Teladoc Health Price Performance

The company has a 50 day moving average price of $9.17 and a 200 day moving average price of $9.64. The company has a market capitalization of $1.13 billion, a P/E ratio of -1.12 and a beta of 1.73. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings results on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.07). Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The company had revenue of $640.49 million during the quarter, compared to analyst estimates of $639.44 million. On average, equities analysts predict that Teladoc Health, Inc. will post -1.16 EPS for the current fiscal year.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.